Medicare Turns Gimlet Eye on DME Drugs

(MedPage Today) -- VEGF inhibitors, such as ranibizumab (Lucentis) or bevacizumab (Avastin), may improve vision in patients with diabetic macular edema, but more research is needed, according to a Medicare advisory panel.

Full Story →